Executive appointment at Xenon
This article was originally published in Scrip
Xenon Pharmaceuticals has appointed Dr Tarek Mansour as its executive vice-president of research and development. Dr Mansour recently served as vice-president, chemical sciences head over multiple research sites at Wyeth (now Pfizer) and has spent over 25 years in the industry. Xenon is a privately owned clinical genetics-based drug discovery company based in Vancouver, Canada, that has two pain medicine candidates in early-stage clinical development.